Intec Pharma Ltd.
- Country
- 🇮🇱Israel
- Ownership
- Private, Subsidiary
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://intecpharma.com
Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients
- Conditions
- Parkinson Disease
- Interventions
- Drug: Sinemet CR 25Mg-100Mg Extended-Release TabletDrug: Accordion Pill Carbidopa/Levodopa
- First Posted Date
- 2018-07-03
- Last Posted Date
- 2018-07-05
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT03576638
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
- Conditions
- Parkinson's Disease
- Interventions
- Drug: Accordion Pillâ„¢ Carbidopa/Levodopa
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 460
- Registration Number
- NCT02615873
- Locations
- 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
🇺🇸Parkinson's Disease & Movement Disorders Center, Fountain Valley, California, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
- Conditions
- Parkinson's Disease
- Interventions
- Drug: Sinemet®Drug: Accordion Pill™ Carbidopa/LevodopaDrug: Placebo- SinemetDrug: Placebo -AP-CD/LD
- First Posted Date
- 2015-11-16
- Last Posted Date
- 2019-08-08
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 420
- Registration Number
- NCT02605434
- Locations
- 🇩🇪
Praxis für Neurologie und Psychiatrie, Westerstede, Germany
🇺🇸Charlottesville Medical Research, Charlottesville, Virginia, United States
🇬🇧Fairfield General Hospital, Bury, United Kingdom
A Polysomnographic Study to Compare the Efficacy of Gastric Retentive Zaleplon Accordion Pill to Placebo in Subjects With Insomnia
- First Posted Date
- 2011-01-14
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 83
- Registration Number
- NCT01277107
- Locations
- 🇮🇱
Rambam sleep center, Haifa, Israel
🇺🇸CRG of St. Petersburg, St. Petersburg, Florida, United States
🇺🇸Vince and Associates Clinical Research, Overland Park, Kansas, United States
Comparison of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep
- Conditions
- Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep
- Interventions
- Drug: IN 10 003 formulation ADrug: IN 10 003 formulation BDrug: Placebo capsules
- First Posted Date
- 2010-09-08
- Last Posted Date
- 2011-05-03
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01196650
- Locations
- 🇮🇱
Soroka University Medical Center, Beer Sheva, Israel
🇮🇱Rambam Medical Center, Haifa, Israel
🇮🇱Assuta Medical Center, Tel Aviv, Israel
Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study
- Conditions
- Parkinson's Disease
- Interventions
- Drug: AP-CD/LD
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2015-11-24
- Lead Sponsor
- Intec Pharma Ltd.
- Registration Number
- NCT00947037
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
🇮🇱Wolfson Medical Center, Holon, Israel
🇮🇱Rabin Medical Center, Petah Tikva, Israel
An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease
- Conditions
- Parkinson's Disease
- Interventions
- Drug: AP09004Drug: Carbidopa/Levodopa, immediate release
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2014-05-28
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT00918177
- Locations
- 🇮🇱
Barzilai Medical Center, Department of Neurology, Movement disorders unit,, Ashkelon,, Israel
🇮🇱Sheba Medical Center, Ramat Gan, Israel
🇮🇱Rambam Health Care Campus, Haifa, Movement Disorders and Parkinson's Disease, Haifa, Israel